{"id":1189,"date":"2022-05-20T15:12:22","date_gmt":"2022-05-20T13:12:22","guid":{"rendered":"https:\/\/www.omikronitalia.it\/ricerca-e-sviluppo\/"},"modified":"2026-02-09T11:47:23","modified_gmt":"2026-02-09T10:47:23","slug":"research-and-development","status":"publish","type":"page","link":"https:\/\/www.omikronitalia.it\/en\/research-and-development\/","title":{"rendered":"Research and Development"},"content":{"rendered":"[vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#ffffff&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; advanced_gradient_angle=&#8221;0&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;zoom-out-slow&#8221; parallax_bg=&#8221;true&#8221; parallax_bg_speed=&#8221;fast&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_row_inner column_margin=&#8221;100px&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;80&#8243; custom_height_phone=&#8221;15&#8243;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;40&#8243; custom_height_phone=&#8221;0&#8243;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<h1 style=\"text-align: left;\">Research and Development<\/h1>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243; custom_height_phone=&#8221;10&#8243;][vc_column_text]\n<h6>Every year Omikron Italia invests about 15% of its turnover in Research and Development on projects carried out in collaboration with the most prestigious Italian and foreign Institutes.<\/h6>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243; custom_height_phone=&#8221;10&#8243;][vc_column_text]The Main Fields of Research are the following:<\/p>\n<ul>\n<li>Glaucoma and other Neurodegenerative Ophthalmic diseases<\/li>\n<li>Diabetic Retinopathy<\/li>\n<li>Experimental studies on vascular contractility and permeability<\/li>\n<li>Hemorrhoidal Disease<\/li>\n<\/ul>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;15&#8243; custom_height_phone=&#8221;0&#8243;][nectar_btn size=&#8221;medium&#8221; open_new_tab=&#8221;true&#8221; button_style=&#8221;regular&#8221; button_color_2=&#8221;Accent-Color&#8221; icon_family=&#8221;none&#8221; text=&#8221;Discover more&#8221; url=&#8221;#more&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;0&#8243; custom_height_phone=&#8221;10&#8243;][\/vc_column_inner][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; translate_y=&#8221;80&#8243; translate_y_phone=&#8221;0px&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; zindex=&#8221;999&#8243; advanced_gradient_angle=&#8221;0&#8243; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221; gradient_type=&#8221;default&#8221;][image_with_animation image_url=&#8221;413&#8243; image_size=&#8221;full&#8221; animation_type=&#8221;entrance&#8221; animation=&#8221;Fade In&#8221; hover_animation=&#8221;none&#8221; alignment=&#8221;&#8221; border_radius=&#8221;none&#8221; box_shadow=&#8221;none&#8221; image_loading=&#8221;default&#8221; max_width=&#8221;100%&#8221; max_width_mobile=&#8221;default&#8221;][\/vc_column_inner][\/vc_row_inner][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;0&#8243; custom_height_phone=&#8221;40&#8243;][\/vc_column][\/vc_row][vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#efefef&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; id=&#8221;more&#8221; advanced_gradient_angle=&#8221;154&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;150&#8243; custom_height_phone=&#8221;60&#8243;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<h2 style=\"text-align: left;\">The Main Fields of Research<\/h2>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;50&#8243; custom_height_phone=&#8221;30&#8243;][vc_row_inner column_margin=&#8221;100px&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;]<div class=\"iwithtext\"><div class=\"iwt-icon\"> <img decoding=\"async\" src=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/icon_1.svg\" alt=\"\" \/> <\/div><div class=\"iwt-text\"> \n<h6>Glaucoma and other Neurodegenerative Ophthalmic deaseases<\/h6>\n <\/div><div class=\"clear\"><\/div><\/div>[vc_column_text]\n<ul>\n<li>A randomized clinical trial (RCT) conducted with citicoline oral solution and functional Magnetic Resonance Imaging with tractography was published in an International Journal. This trial evaluated and explained for the first time worldwide the central effect of a neuroprotective agent in glaucoma patients.<\/li>\n<li>The first controlled clinical study versus placebo which evaluated the effect of a medical treatment on the quality of life in glaucomatous patients was published in an International Journal. In particular, this international, multicenter, randomized, placebo controlled, cross-over clinical study evaluated the effect of citicoline in oral solution on quality of life in patients with glaucoma.<\/li>\n<li>An in vitro study which demonstrated that in a 3D glaucoma model the topical treatment with citicoline in ophthalmic solution protects trabecular meshwork cells from oxidative stress injuries was published in an International Journal.<\/li>\n<li>A multicenter clinical trial with citicoline in ophthalmic solution in glaucomatous patients with progression damage was concluded and published in an International Journal; this trial has been performed by Italian University Institutes and provided morphological and functional evaluations.<\/li>\n<li>A clinical trial, carried out by an Italian Research Institute, with citicoline oral solution in the treatment of patients with neurodegenerative diseases involving the optic nerve was published in an International Journal.<\/li>\n<li>An ocular kinetics study in human performed with citicoline in ophthalmic solution in patients undergoing vitrectomy was published in an International Journal.<\/li>\n<li>A clinical study carried out by an Italian Research Institute with liposomal citicoline in ophthalmic solution in the treatment of glaucomatous patients was published in an International Journal.<\/li>\n<li>A clinical trial performed by an Italian Research Institute with citicoline in ophthalmic solution in the treatment of glaucomatous patients was ended and published in an International Journal.<\/li>\n<li>The first multicenter trial with citicoline oral solution, never carried out before on the progression of the campimetric damage in glaucomatous patients has been published in an International Journal.<\/li>\n<li>The preclinical and clinical development of OMK1\u00ae, citicoline and hyaluronic acid in ophthalmic solution (Medical Device CE), of OMK2\u00ae, citicoline, hyaluronic acid and vitamin B12 in ophthalmic solution (Medical Device CE) and of OMK1\u00ae-LF citicoline and hyaluronic acid in liposomal ophthalmic solution without preservatives (Medical Device CE) was carried out in Italy.<\/li>\n<\/ul>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;][\/vc_column_inner][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;]<div class=\"iwithtext\"><div class=\"iwt-icon\"> <img decoding=\"async\" src=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/icon_2.svg\" alt=\"\" \/> <\/div><div class=\"iwt-text\"> \n<h6>Diabetic Retinopathy<\/h6>\n <\/div><div class=\"clear\"><\/div><\/div>[vc_column_text]\n<ul>\n<li>A clinical trial, performed by an Italian University Institute, on corneal morphology and functionality in patients with advanced stage diabetic neuropathy treated with citicoline and Vit B12 in ophthalmic solution was published in International Journal.<\/li>\n<li>A clinical trial, performed by an Italian Research Institute, in patients with incipient Diabetic Retinopathy treated with citicoline and Vit B12 in ophthalmic solution was published in International Journal.<\/li>\n<li>An experimental trial on animals with induced Diabetic Retinopathy in treatment with liposomal citicoline in ophthalmic solution, performed by a Spanish University Institute, was published in International Journal.<\/li>\n<li>An experimental Trial on animals with induced Diabetic Retinopathy in treatment with citicoline and Vit B12 in ophthalmic solution, performed by an Italian University Institute, was published in International Journal.<\/li>\n<li>An experimental trial, performed by the National Health Institute (Istituto Superiore di Sanit\u00e0), in vitro on retinal cell cultures and in vivo with rats to evaluate the neuroprotective effect of treatment with citicoline and Vit B12 in ophthalmic solution on the possible structural and functional alterations of the retinal neuroglial component in the diabetic disease was published in an International Journal.<\/li>\n<\/ul>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;]<div class=\"iwithtext\"><div class=\"iwt-icon\"> <img decoding=\"async\" src=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/icon_3.svg\" alt=\"\" \/> <\/div><div class=\"iwt-text\"> \n<h6>Experimental studies on vascular contractility and permeability<\/h6>\n <\/div><div class=\"clear\"><\/div><\/div>[divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;]<div class=\"iwithtext\"><div class=\"iwt-icon\"> <img decoding=\"async\" src=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/icon_4.svg\" alt=\"\" \/> <\/div><div class=\"iwt-text\"> \n<h6>Chronic Venous Insufficiency<\/h6>\n <\/div><div class=\"clear\"><\/div><\/div>[vc_column_text]\n<ul>\n<li>A clinical study conducted at the University of Modena and Reggio Emilia \u2013 Unimore, cross-over and placebo-controlled, evaluating the efficacy of a combination of diosmin, troxerutin and hesperidin in the management of signs and symptoms in patients with pelvic congestion syndrome has been published.<\/li>\n<\/ul>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;]<div class=\"iwithtext\"><div class=\"iwt-icon\"> <img decoding=\"async\" src=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/icon_5.svg\" alt=\"\" \/> <\/div><div class=\"iwt-text\"> \n<h6>Hemorrhoidal Disease<\/h6>\n <\/div><div class=\"clear\"><\/div><\/div>[vc_column_text]\n<ul>\n<li>A clinical study conducted at an Italian University Institute has been published in an International Journal, demonstrating the effectiveness of CONAN\u00ae proctological cream (CE Medical Device) in improving the signs and symptoms associated with hemorrhoids and anal fissures.<\/li>\n<li>A multicenter, prospective, randomized, controlled, triple-blind clinical study, performed independently by the Italian Society of Colo-Rectal Surgery (SICCR) to evaluate the efficacy of a mixture of flavonoids in the treatment of acute hemorrhoidal disease was published in an International Journal.<\/li>\n<li>The preclinical and clinical development of a new formulation for topical use in the treatment of hemorrhoids, CONAN\u00ae proctological cream (Medical Device CE) was performed.<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;100&#8243; custom_height_phone=&#8221;40&#8243;][\/vc_column][\/vc_row][vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#efefef&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; id=&#8221;more&#8221; advanced_gradient_angle=&#8221;154&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][tabbed_section style=&#8221;material&#8221; alignment=&#8221;left&#8221; spacing=&#8221;default&#8221; tab_color=&#8221;Accent-Color&#8221; vs_content_animation=&#8221;fade&#8221; vs_link_animation=&#8221;opacity&#8221; vs_navigation_alignment=&#8221;left&#8221; vs_navigation_width_2=&#8221;25%&#8221; vs_navigation_func=&#8221;default&#8221; vs_navigation_width=&#8221;regular&#8221; vs_navigation_spacing=&#8221;15px&#8221; vs_navigation_mobile_display=&#8221;visible&#8221; vs_tab_spacing=&#8221;5%&#8221; icon_size=&#8221;24&#8243; el_class=&#8221;ricerca-e-sviluppo&#8221;][tab icon_family=&#8221;none&#8221; title=&#8221;Products Under Development&#8221; id=&#8221;1770633841883-7&#8243; tab_id=&#8221;1770633841884-4&#8243;][vc_column_text]\n<div id=\"tab1\" style=\"overflow-x: auto;\">\n<table border=\"0\" cellspacing=\"4\" cellpadding=\"2\">\n<tbody>\n<tr>\n<th scope=\"col\">THERAPEUTIC AREA<\/th>\n<th scope=\"col\">PHARMACEUTICAL FORM<\/th>\n<th scope=\"col\">EXPECTED LAUNCH<\/th>\n<\/tr>\n<tr>\n<td>Ophthalmology\/Glaucoma<\/td>\n<td>eye-drops<\/td>\n<td>2028<\/td>\n<\/tr>\n<tr>\n<td>Vascular disease (Antithrombotic)<\/td>\n<td>solution for injection<\/td>\n<td>2027<\/td>\n<\/tr>\n<tr>\n<td>Vascular (OP-I-01)<\/td>\n<td>ution for injection<\/td>\n<td>2028<\/td>\n<\/tr>\n<tr>\n<td>Vascular (OP-I-02)<\/td>\n<td>solution for injection<\/td>\n<td>2028<\/td>\n<\/tr>\n<tr>\n<td>Vascular (OP-I-03)<\/td>\n<td>solution for injection<\/td>\n<td>2028<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n[\/vc_column_text][\/tab][tab icon_family=&#8221;none&#8221; title=&#8221;International Patents&#8221; id=&#8221;1770633841892-1&#8243; tab_id=&#8221;1770633841892-2&#8243;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<div id=\"tab2\" class=\"tab-pane fade \">\n<h5>Patent Application: PCT\/IB2011\/050663<br \/>\nTitle document: TOPICAL CITICOLINE FOR THE TREATMENT OF GLAUCOMA<\/h5>\n<\/div>\n[\/vc_column_text][vc_column_text]\n<div id=\"tab2\" class=\"tab-pane fade\" style=\"overflow-x: auto;\">\n<table style=\"width: 100%;\" border=\"0\" cellspacing=\"4\" cellpadding=\"2\">\n<tbody>\n<tr>\n<th scope=\"col\"><\/th>\n<th scope=\"col\">APPLICATION NUMBER<\/th>\n<th scope=\"col\">PUBLICATION<\/th>\n<th scope=\"col\">STATUS<\/th>\n<th scope=\"col\">TITLE DOCUMENT HOLDER (PATENT HOLDER)<\/th>\n<\/tr>\n<tr>\n<td>PCT<\/td>\n<td>WO2011101802<\/td>\n<td>25\/08\/2011<\/td>\n<td><\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>EUROPE<br \/>\n<a href=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/Omikron-Brevetto-Europa.pdf\" target=\"_blank\" rel=\"noopener\">EP2538918<\/a><\/td>\n<td>19\/11\/2014<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>USA<br \/>\n<a href=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/Omikron-Brevetto-USA.pdf\" target=\"_blank\" rel=\"noopener\">US8822429<\/a><\/td>\n<td>02\/09\/2014<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>JAPAN<br \/>\n<a href=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/Omikron-Brevetto-Giappone.pdf\" target=\"_blank\" rel=\"noopener\">JP5801324<\/a><\/td>\n<td>04\/09\/2015<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;30&#8243; custom_height_phone=&#8221;25&#8243;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<div id=\"tab2\" class=\"tab-pane fade \">\n<h5>Patent Application: PCT\/IB2017\/056400<br \/>\nTitle document: OPHTHALMIC FORMULATION COMPRISING CITICOLINE CARRIED BY LIPOSOME FOR THE TREATMENT OF GLAUCOMA<\/h5>\n<\/div>\n[\/vc_column_text][vc_column_text]\n<div id=\"tab2\" class=\"tab-pane fade\" style=\"overflow-x: auto;\">\n<table style=\"width: 100%;\" border=\"0\" cellspacing=\"4\" cellpadding=\"2\">\n<tbody>\n<tr>\n<th scope=\"col\"><\/th>\n<th scope=\"col\">APPLICATION NUMBER<\/th>\n<th scope=\"col\">PUBLICATION<\/th>\n<th scope=\"col\">STATUS<\/th>\n<th scope=\"col\">TITLE DOCUMENT HOLDER<br \/>\n(PATENT HOLDER)<\/th>\n<\/tr>\n<tr>\n<td>PCT<\/td>\n<td>WO2018073720<\/td>\n<td>26\/04\/2018<\/td>\n<td><\/td>\n<td><\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>USA<br \/>\n<a href=\"https:\/\/www.omikronitalia.it\/shooglat\/2022\/06\/Omikron-Patent-USA.pdf\" target=\"_blank\" rel=\"noopener\">US 10576039<\/a><\/td>\n<td>03\/03\/2020<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>Mexico<\/td>\n<td>17\/12\/2021<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>Japan<\/td>\n<td>16\/03\/2022<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<tr>\n<td>NATIONAL STAGE<\/td>\n<td>Eurasia<\/td>\n<td>23\/11\/2022<\/td>\n<td>GRANT OF PATENT IS INTENDED<\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n[\/vc_column_text][vc_column_text el_class=&#8221;accent-color&#8221;]\n<div id=\"tab2\" class=\"tab-pane fade \">\n<h5>Patent Application: PCT\/IB2022\/054202<br \/>\nTitle document: ORAL SOLUTION WITH HIGH BIOAVAILABILITY CONTAINING CITICOLINE AND NICOTINAMMIDE<\/h5>\n<\/div>\n[\/vc_column_text][vc_column_text]\n<div id=\"tab2\" class=\"tab-pane fade\" style=\"overflow-x: auto;\">\n<table style=\"width: 100%;\" border=\"0\" cellspacing=\"4\" cellpadding=\"2\">\n<tbody>\n<tr>\n<th scope=\"col\"><\/th>\n<th scope=\"col\">APPLICATION NUMBER<\/th>\n<th scope=\"col\">PUBLICATION<\/th>\n<th scope=\"col\">STATUS<\/th>\n<th scope=\"col\">TITLE DOCUMENT HOLDER<br \/>\n(PATENT HOLDER)<\/th>\n<\/tr>\n<tr>\n<td>PCT<\/td>\n<td>WO2022\/238822 A1<\/td>\n<td>17\/11\/2022<\/td>\n<td><\/td>\n<td>OMIKRON ITALIA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n[\/vc_column_text][\/tab][tab icon_family=&#8221;none&#8221; title=&#8221;Licensing in&#8221; id=&#8221;1770633841913-7&#8243; tab_id=&#8221;1770633841913-9&#8243;][vc_column_text]\n<div id=\"tab3\" class=\"tab-pane fade active in\" style=\"overflow-x: auto;\">\n<table border=\"0\" cellspacing=\"6\">\n<tbody>\n<tr>\n<td>ABIOGEN PHARMA<br \/>\nPisa &#8211; Italy<\/td>\n<td>Glibenclamide + Meformin Hydrocloride (Diaglimet \u00ae)<br \/>\nRRR-\u03b1-tochoperol (Armilla \u00ae)<\/td>\n<\/tr>\n<tr>\n<td>URSAPHARM Arzneimittel GmbH<br \/>\nGermany<\/td>\n<td>Retinol Palmitate (VitA-POS)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n[\/vc_column_text][\/tab][tab icon_family=&#8221;none&#8221; title=&#8221;Licensing out&#8221; id=&#8221;1770633841916-4&#8243; tab_id=&#8221;1770633841916-0&#8243;][vc_column_text]Thanks to licensing agreements with foreign major pharmaceutical companies, since 2013 Omikron Italia started an important internationalization process that is more and more consolidating and increasing over the years.<\/p>\n<p>Some Omikron Italia medicinal products, medical devices and nutraceuticals are already marketed in several European Countries and Extra European Countries. Moreover, registrations in 3 different continents are currently ongoing.<\/p>\n<p>The continuous innovation of proposed therapeutic approaches together with an increasing attention to the quality of the products, to the interest towards the therapeutic needs of patients and to the constant efforts in Research allowed Omikron Italia to steadily expand over the years in many Countries.[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;][nectar_btn size=&#8221;medium&#8221; open_new_tab=&#8221;true&#8221; button_style=&#8221;regular&#8221; button_color_2=&#8221;Accent-Color&#8221; icon_family=&#8221;none&#8221; text=&#8221;Partnership Map&#8221; url=&#8221;#map&#8221;][\/tab][\/tabbed_section][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;100&#8243; custom_height_phone=&#8221;60&#8243;][\/vc_column][\/vc_row][vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#efefef&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; id=&#8221;map&#8221; advanced_gradient_angle=&#8221;154&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<h2 style=\"text-align: left;\">Partnership Map<\/h2>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243; custom_height_phone=&#8221;10&#8243;][vc_raw_html]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[\/vc_raw_html][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243; custom_height_phone=&#8221;10&#8243;][vc_column_text]<div id=\"mapplic-id677\" data-mapdata=\"{&quot;mapwidth&quot;:&quot;1200&quot;,&quot;mapheight&quot;:&quot;760&quot;,&quot;action&quot;:&quot;tooltip&quot;,&quot;fillcolor&quot;:&quot;#343f4b&quot;,&quot;maxscale&quot;:&quot;2&quot;,&quot;customcss&quot;:&quot;span.mapplic-legend-key {\\n    margin-top: 3px;\\n}\\n\\n.mapplic-legend {\\n    display: none;\\n}&quot;,&quot;fullscreen&quot;:false,&quot;hovertip&quot;:true,&quot;hovertipdesc&quot;:false,&quot;smartip&quot;:false,&quot;deeplinking&quot;:true,&quot;linknewtab&quot;:false,&quot;minimap&quot;:false,&quot;animations&quot;:false,&quot;zoom&quot;:true,&quot;zoombuttons&quot;:true,&quot;clearbutton&quot;:true,&quot;zoomoutclose&quot;:true,&quot;closezoomout&quot;:false,&quot;mousewheel&quot;:true,&quot;mapfill&quot;:false,&quot;sidebar&quot;:false,&quot;search&quot;:false,&quot;searchdescription&quot;:false,&quot;alphabetic&quot;:false,&quot;thumbholder&quot;:false,&quot;sidebartoggle&quot;:false,&quot;filtersopened&quot;:false,&quot;highlight&quot;:false,&quot;levels&quot;:[{&quot;id&quot;:&quot;world&quot;,&quot;title&quot;:&quot;World&quot;,&quot;map&quot;:&quot;\\\/\\\/www.omikronitalia.it\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/world.svg&quot;,&quot;minimap&quot;:&quot;&quot;}],&quot;styles&quot;:[],&quot;categories&quot;:[{&quot;title&quot;:&quot;Paesi con presenza diretta&quot;,&quot;id&quot;:&quot;presenza-diretta&quot;,&quot;about&quot;:&quot;&quot;,&quot;icon&quot;:&quot;&quot;,&quot;legend&quot;:&quot;true&quot;,&quot;color&quot;:&quot;#b23427&quot;},{&quot;title&quot;:&quot;Paesi con presenza indiretta (commercializzazione di prodotti Omikron Italia tramite Aziende partner)&quot;,&quot;id&quot;:&quot;presenza-indiretta-1&quot;,&quot;about&quot;:&quot;&quot;,&quot;icon&quot;:&quot;&quot;,&quot;legend&quot;:&quot;true&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Paesi con presenza indiretta (accordi di commercializzazione di prodotti Omikron Italia con pratiche registrative in corso)&quot;,&quot;id&quot;:&quot;presenza-indiretta-2&quot;,&quot;about&quot;:&quot;&quot;,&quot;icon&quot;:&quot;&quot;,&quot;legend&quot;:&quot;true&quot;,&quot;color&quot;:&quot;#e7988f&quot;}],&quot;locations&quot;:[{&quot;title&quot;:&quot;Kazakistan&quot;,&quot;id&quot;:&quot;kz&quot;,&quot;description&quot;:&quot;&lt;p&gt;OMK1 - OMK2&lt;\\\/p&gt;&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6718&quot;,&quot;y&quot;:&quot;0.4638&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Uzbekistan&quot;,&quot;id&quot;:&quot;uz&quot;,&quot;description&quot;:&quot;&lt;p&gt;OMK1 - OMK2&lt;\\\/p&gt;&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6670&quot;,&quot;y&quot;:&quot;0.5063&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Kirghizistan&quot;,&quot;id&quot;:&quot;kg&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6963&quot;,&quot;y&quot;:&quot;0.5051&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Tagikistan&quot;,&quot;id&quot;:&quot;tj&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6837&quot;,&quot;y&quot;:&quot;0.5213&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Turkey&quot;,&quot;id&quot;:&quot;tr&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5950&quot;,&quot;y&quot;:&quot;0.5188&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Georgia&quot;,&quot;id&quot;:&quot;ge&quot;,&quot;description&quot;:&quot;OMK1 - OMK2 - TREPARIN 250 L.R.U.&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6148&quot;,&quot;y&quot;:&quot;0.5013&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Azerbaijan&quot;,&quot;id&quot;:&quot;az&quot;,&quot;description&quot;:&quot;OMK1 - OMK2 - TREPARIN 250 L.R.U. - TRIADE - TRIADE CREMA GEL - NEUKRON - OMKASA - MICROFLEB - NEUROTIDINE - TRIADE H - TREPARIN 600 L.R.U.&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6262&quot;,&quot;y&quot;:&quot;0.5113&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Iran&quot;,&quot;id&quot;:&quot;ir&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#e7988f&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.6362&quot;,&quot;y&quot;:&quot;0.5413&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#e7988f&quot;},{&quot;title&quot;:&quot;Korea&quot;,&quot;id&quot;:&quot;kr&quot;,&quot;description&quot;:&quot;VisNeurox OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#e7988f&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.8373&quot;,&quot;y&quot;:&quot;0.5351&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#e7988f&quot;},{&quot;title&quot;:&quot;Philippines&quot;,&quot;id&quot;:&quot;ph&quot;,&quot;description&quot;:&quot;VisNeurox OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.8222&quot;,&quot;y&quot;:&quot;0.6438&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#e7988f&quot;,&quot;fill&quot;:&quot;#e7988f&quot;},{&quot;title&quot;:&quot;Egypt&quot;,&quot;id&quot;:&quot;eg&quot;,&quot;description&quot;:&quot;VisNeurox OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#e7988f&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5776&quot;,&quot;y&quot;:&quot;0.5788&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#e7988f&quot;},{&quot;title&quot;:&quot;Mexico&quot;,&quot;id&quot;:&quot;mx&quot;,&quot;description&quot;:&quot;Citoneurox OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.2326&quot;,&quot;y&quot;:&quot;0.6016&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Chile&quot;,&quot;id&quot;:&quot;cl&quot;,&quot;description&quot;:&quot;VisNeurox OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.3140&quot;,&quot;y&quot;:&quot;0.8051&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Portugal&quot;,&quot;id&quot;:&quot;pt&quot;,&quot;description&quot;:&quot;ETE CARE OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.4796&quot;,&quot;y&quot;:&quot;0.5140&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Spain&quot;,&quot;id&quot;:&quot;es&quot;,&quot;description&quot;:&quot;Omikron Espa\\u00f1a (Spain)&lt;br&gt;\\nVISNEUROX OMK1 - VISNEUROX B12 OMK2&lt;br&gt;\\n&lt;a href=\\&quot;https:\\\/\\\/www.omikronitalia.it\\\/es\\\/\\&quot; rel=\\&quot;noopener\\&quot; target=\\&quot;_blank\\&quot;&gt;Visita il sito&lt;\\\/a&gt;&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#b23427&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.4913&quot;,&quot;y&quot;:&quot;0.5019&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#b23427&quot;},{&quot;title&quot;:&quot;Italy&quot;,&quot;id&quot;:&quot;it&quot;,&quot;description&quot;:&quot;Omikron Italia S.r.l. (Italy)&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#b23427&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5238&quot;,&quot;y&quot;:&quot;0.4901&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#b23427&quot;},{&quot;title&quot;:&quot;France&quot;,&quot;id&quot;:&quot;fr&quot;,&quot;description&quot;:&quot;NEURODROP OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5096&quot;,&quot;y&quot;:&quot;0.4705&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Belarus&quot;,&quot;id&quot;:&quot;by&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5673&quot;,&quot;y&quot;:&quot;0.4288&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;},{&quot;title&quot;:&quot;Ukraine&quot;,&quot;id&quot;:&quot;ua&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5839&quot;,&quot;y&quot;:&quot;0.4638&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;OMK1 - OMK2&quot;},{&quot;title&quot;:&quot;Poland&quot;,&quot;id&quot;:&quot;pl&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5570&quot;,&quot;y&quot;:&quot;0.4401&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;CITOGA VIS OMK1 - RETINACIT OMK2&quot;},{&quot;title&quot;:&quot;Czechia&quot;,&quot;id&quot;:&quot;cz&quot;,&quot;description&quot;:&quot;OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5410&quot;,&quot;y&quot;:&quot;0.4560&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Slovakia&quot;,&quot;id&quot;:&quot;sk&quot;,&quot;description&quot;:&quot;OMK1&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5540&quot;,&quot;y&quot;:&quot;0.4635&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;},{&quot;title&quot;:&quot;Belgium&quot;,&quot;id&quot;:&quot;be&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5158&quot;,&quot;y&quot;:&quot;0.4507&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;NEURODROP OMK1&quot;},{&quot;title&quot;:&quot;Romania&quot;,&quot;id&quot;:&quot;ro&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5625&quot;,&quot;y&quot;:&quot;0.4776&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;OMK1 - OMK2 - NEUKRON OFTA MESE&quot;},{&quot;title&quot;:&quot;Serbia&quot;,&quot;id&quot;:&quot;rs&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5587&quot;,&quot;y&quot;:&quot;0.4912&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;NEUKRON OFTA MESE&quot;},{&quot;title&quot;:&quot;Bulgaria&quot;,&quot;id&quot;:&quot;bg&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5669&quot;,&quot;y&quot;:&quot;0.5010&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;OMK1 - NEURETIN&quot;},{&quot;title&quot;:&quot;Greece&quot;,&quot;id&quot;:&quot;gr&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5587&quot;,&quot;y&quot;:&quot;0.5182&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;OMK2 - TRIADE CREMA GEL - NEUKRON OFTA MESE&quot;},{&quot;title&quot;:&quot;North Macedonia&quot;,&quot;id&quot;:&quot;mk&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#db6659&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.5594&quot;,&quot;y&quot;:&quot;0.5037&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#db6659&quot;,&quot;description&quot;:&quot;CITIKOL B&quot;},{&quot;title&quot;:&quot;Russia&quot;,&quot;id&quot;:&quot;ru&quot;,&quot;description&quot;:&quot;&lt;p&gt;TREPARIN 250 L.R.U.&lt;\\\/p&gt;&quot;,&quot;pin&quot;:&quot;hidden&quot;,&quot;fill&quot;:&quot;#e7988f&quot;,&quot;action&quot;:&quot;default&quot;,&quot;x&quot;:&quot;0.7367&quot;,&quot;y&quot;:&quot;0.3526&quot;,&quot;level&quot;:&quot;world&quot;,&quot;color&quot;:&quot;#e7988f&quot;,&quot;category&quot;:&quot;presenza-indiretta-2&quot;}]}\"><\/div> [\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;100&#8243; custom_height_phone=&#8221;60&#8243;][\/vc_column][\/vc_row][vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#efefef&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; id=&#8221;more&#8221; advanced_gradient_angle=&#8221;154&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;none&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; column_position=&#8221;default&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/1&#8243; tablet_width_inherit=&#8221;default&#8221; tablet_text_alignment=&#8221;default&#8221; phone_text_alignment=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][vc_row_inner equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221; column_margin=&#8221;100px&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; text_align=&#8221;left&#8221; row_position=&#8221;default&#8221; row_position_tablet=&#8221;inherit&#8221; row_position_phone=&#8221;inherit&#8221; overflow=&#8221;visible&#8221; pointer_events=&#8221;all&#8221;][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][image_with_animation image_url=&#8221;427&#8243; image_size=&#8221;full&#8221; animation_type=&#8221;entrance&#8221; animation=&#8221;Fade In From Left&#8221; hover_animation=&#8221;none&#8221; alignment=&#8221;&#8221; border_radius=&#8221;none&#8221; box_shadow=&#8221;none&#8221; image_loading=&#8221;default&#8221; max_width=&#8221;100%&#8221; max_width_mobile=&#8221;default&#8221;][\/vc_column_inner][vc_column_inner column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243; column_shadow=&#8221;none&#8221; column_border_radius=&#8221;none&#8221; column_link_target=&#8221;_self&#8221; gradient_direction=&#8221;left_to_right&#8221; overlay_strength=&#8221;0.3&#8243; width=&#8221;1\/2&#8243; tablet_width_inherit=&#8221;default&#8221; animation_type=&#8221;default&#8221; bg_image_animation=&#8221;none&#8221; border_type=&#8221;simple&#8221; column_border_width=&#8221;none&#8221; column_border_style=&#8221;solid&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;0&#8243; custom_height_phone=&#8221;15&#8243;][image_with_animation image_url=&#8221;429&#8243; image_size=&#8221;full&#8221; animation_type=&#8221;entrance&#8221; animation=&#8221;Fade In&#8221; hover_animation=&#8221;none&#8221; alignment=&#8221;&#8221; border_radius=&#8221;none&#8221; box_shadow=&#8221;none&#8221; image_loading=&#8221;default&#8221; max_width=&#8221;100%&#8221; max_width_mobile=&#8221;default&#8221;][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;40&#8243; custom_height_phone=&#8221;15&#8243;][vc_column_text el_class=&#8221;accent-color&#8221;]\n<h3 style=\"text-align: left;\">Research Award A.I.S.G. \u2013 Omikron Italia 2023 \u201cMarco Centofanti\u201d su: Neuroprotezione e Glaucoma<\/h3>\n[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;6&#8243;][vc_column_text]Omikron Italia, a leading company in the ophthalmic sector, intends to actively contribute to the development of research in Italy through funding for 2 young researchers active in the physiopathological and \/ or clinical field relating to Neuroprotection in Glaucoma.<\/p>\n<p>Read and download the complete announcement, fill in the fields indicated and send your Curriculum Vitae together with the full text of the publications of Research Projects previously conducted in the aforementioned area to the e-mail addresses <a href=\"mailto:dir.amministrativa@omikronitalia.it\">dir.amministrativa@omikronitalia.it<\/a> and <a href=\"mailto:oftalmologicaaisg@libero.it\">oftalmologicaaisg@libero.it<\/a> by December 31, 2022.[\/vc_column_text][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;20&#8243;][nectar_btn size=&#8221;medium&#8221; button_style=&#8221;regular&#8221; button_color_2=&#8221;Accent-Color&#8221; icon_family=&#8221;none&#8221; text=&#8221;Get involved&#8221; url=&#8221;https:\/\/www.omikronitalia.it\/en\/bando-premio-di-ricerca-aisg\/&#8221;][\/vc_column_inner][\/vc_row_inner][divider line_type=&#8221;No Line&#8221; custom_height=&#8221;100&#8243; custom_height_phone=&#8221;25&#8243;][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=&#8221;full_width_background&#8221; full_screen_row_position=&#8221;middle&#8221; column_margin=&#8221;default&#8221; column_direction=&#8221;default&#8221; column_direction_tablet=&#8221;default&#8221; column_direction_phone=&#8221;default&#8221; bg_color=&#8221;#ffffff&#8221; scene_position=&#8221;center&#8221; text_color=&#8221;dark&#8221; text_align=&#8221;left&#8221; row_border_radius=&#8221;none&#8221; row_border_radius_applies=&#8221;bg&#8221; overflow=&#8221;visible&#8221; advanced_gradient_angle=&#8221;0&#8243; overlay_strength=&#8221;0.3&#8243; gradient_direction=&#8221;left_to_right&#8221; shape_divider_position=&#8221;bottom&#8221; bg_image_animation=&#8221;zoom-out-slow&#8221; parallax_bg=&#8221;true&#8221; parallax_bg_speed=&#8221;fast&#8221; gradient_type=&#8221;default&#8221; shape_type=&#8221;&#8221;][vc_column column_padding=&#8221;no-extra-padding&#8221; column_padding_tablet=&#8221;inherit&#8221; column_padding_phone=&#8221;inherit&#8221; column_padding_position=&#8221;all&#8221; column_element_spacing=&#8221;default&#8221; background_color_opacity=&#8221;1&#8243; background_hover_color_opacity=&#8221;1&#8243;&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1189","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/pages\/1189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/comments?post=1189"}],"version-history":[{"count":20,"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/pages\/1189\/revisions"}],"predecessor-version":[{"id":5539,"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/pages\/1189\/revisions\/5539"}],"wp:attachment":[{"href":"https:\/\/www.omikronitalia.it\/en\/wp-json\/wp\/v2\/media?parent=1189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}